SquareMind Secures €15.3M for AI Dermatology Platform

SquareMind, a French startup focused on AI and robotics for dermatology, has secured €15.3 million (approximately $18 million) to commercialize its whole-body imaging robot, Swan™. This funding will facilitate the deployment of their advanced dermatological imaging platform under increasing competitive pressure in healthcare technology.

The investment represents a strategic move towards enhancing national expertise in healthcare tech, particularly in robotics and AI-related imaging solutions. By improving its proprietary technologies, SquareMind aims to reduce dependence on foreign systems while addressing healthcare demands with innovative solutions, positioning itself prominently in the burgeoning field of automated medical imaging.